<p>The prevalence of revision and conversion metabolic bariatric surgery (MBS) has increased alongside the growing number of primary Roux-en-Y gastric bypass (RYGB) procedures performed worldwide. Common indications for revision or conversion after RYGB include weight recurrence (WR), suboptimal clinical response (SoCR), and late postoperative complications such as internal hernia, marginal ulcers, malnutrition, dumping syndrome, and post-bariatric hypoglycemia. However, high-quality comparative evidence remains limited, and no international consensus exists regarding optimal management strategies. This study aimed to evaluate current international practices and expert opinions on revision and conversion surgery after RYGB through a global expert survey. This international online binary survey comprised 61 questions and was conducted via SurveyMonkey™ between November 14 and December 10, 2025. A total of 188 specialists participated (75.2% of invitees), with 184 completing the questionnaire (98% completion rate). Item-specific response rates ranged from 177 to 187. The survey demonstrated broad international agreement that WR and SoCR are multifactorial conditions requiring individualized, multidisciplinary management. Endoscopic approaches were generally favored as first-line options in selected patients with anatomical dilation, whereas hypoabsorptive procedures (distal RYGB, SADI-S, BPD-DS) were considered more effective for long-term weight loss and metabolic outcomes. High agreement (&gt; 90%) was observed for multidisciplinary follow-up, individualized procedure selection, lifelong nutritional surveillance, and management of several late complications. Important areas of controversy remain. These findings provide preliminary insights that may support future standardized definitions, clinical pathways, and evidence-based guidelines.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Current practices in revision/conversion surgery after Roux-en-Y gastric bypass: an international binary expert survey

  • Carlos Augusto Madalosso,
  • Mohammad Kermansaravi,
  • Victor Dib,
  • Sonja Chiappetta,
  • Chetan Parmar,
  • Andrea Lazzati,
  • Violeta Moize,
  • Omar M. Ghanem,
  • Edo Aarts,
  • Almino Ramos,
  • Luciano Antozzi,
  • Luiz D. Almeida,
  • Christine Stier,
  • Nasreen Alfaris,
  • Mary O’Kane,
  • Richard Peterson,
  • Scott A. Shikora,
  • Paulo Reis,
  • Maurizio De Luca,
  • Rafael Antoniazzi Abaid,
  • Syed Imran Abbas,
  • Mujjahid Abbas,
  • Ahmed Abdelmoatamed Abokhozima,
  • Reza Adib,
  • Ebrahim Aghajani,
  • Suhaib Ahmad,
  • Faki Akin,
  • Mohammed Al Hadad,
  • Hazem Al Momani,
  • Badar Aflah AlHadhrami,
  • Aayed Robiaan Alqahtani,
  • Saud Abdullah Alsubaie,
  • Glauco da Costa Alvarez,
  • Erivaldo Santos Alves,
  • Luigi Angrisani,
  • Priscila Antozzi,
  • Manuel Aceves Avalos,
  • Sofiene Ayadi,
  • Jose M. Balibrea,
  • Ahmet Ziya Balta,
  • Giorgio Alfredo Pedroso Baretta,
  • Ahmad A. Bashir,
  • Estuardo Behrens,
  • Mohamed Ben Amar,
  • Naiara Portugal Dias Bicalho,
  • Tuna Bilecik,
  • Cynthia-Michelle Borg,
  • Italo Braghetto,
  • Jorge Bravo,
  • Walid Lutfi Bukhari,
  • Daniel Oscar Caiña,
  • Miguel Angel Carbajo,
  • Sidney Silva Chalub,
  • Mounir Ben Chatouh,
  • Rodrigue Georges Chemaly,
  • Benjamin Clapp,
  • Jerome Dargent,
  • Cristóbal Alfredo Davanzo,
  • AmirHossein Davarpanah Jazi,
  • Luiz Alberto De Carli,
  • Muhammed Taha Demirpolat,
  • Nicola Di Lorenzo,
  • Bruno Roger Dillemans,
  • Carlos Frota Dillenburg,
  • João Henrique Felicio De Lima,
  • Daniel Moritz Felsenreich,
  • Rodrigo Oliveira Fernandes,
  • Admar Concon Filho,
  • Nicholas Finer,
  • Michel Gagner,
  • Manoel Galvao Neto,
  • Amador Garcia Ruiz de Gordejuela,
  • Tikfu Gee,
  • Daniel Gero,
  • Bijan Ghavami,
  • Ramen Goel,
  • Kevin Göttgens,
  • Guilherme Sposito Ribeiro Goyano,
  • Yitka Nora Helena Graham,
  • Eduardo Grecco,
  • Tamer A. A. M. Habeeb,
  • Mohamed Hany,
  • Miguel F. Herrera,
  • Kelvin Dwight HigaHiga,
  • Jacques M. Himpens,
  • Farah Anwari Husain,
  • Antonio Iannelli,
  • Richa Jaiswal,
  • Kazunori Kasama,
  • Radwan Kassir,
  • Diogo Swain Kfouri,
  • Amir Ulhaq Khan,
  • Nesreen Khidir,
  • Mousa A. R. Khoursheed,
  • Sang Hyun Kim,
  • Cuneyt Kirkil,
  • Felipe José Koleski,
  • Shanu Nikhil Kothari,
  • Lilian Kow,
  • Klaus Michael Kramer,
  • Jon Adalsteinn Kristinsson,
  • Matthew Kroh,
  • Marina S. Kurian,
  • Panagiotis Lainas,
  • Laurent Abram Layani,
  • Wei Jei Lee,
  • Silvia Leite,
  • Enrique Luque-de-León,
  • Kamal Mahawarm,
  • Pedro Rodrigo Martinez Duartez,
  • Ana Carolina Nogueira Martins,
  • Ibrahim Massuqueto Andrade Gomes de Souza,
  • Samer Gamil Mattar,
  • Guilherme S. Mazzini,
  • John Melissas,
  • Karl Anton Miller,
  • Alexander Dimitri Miras,
  • Mohamad Hayssam Elfawal,
  • Rachel Lynn Moore,
  • John Morton,
  • Alaa Abbass Moustafa,
  • Mario Musella,
  • Mariana Calanca Nascimento,
  • Aleksandr Neimark,
  • Muhammad S. Niam,
  • Abdelrahman Nimeri,
  • Patrick Jean François Noel,
  • Hiroji Okano,
  • Taryel Isgender Omarov,
  • Tiago Rafael Onzi,
  • Mariano Palermo,
  • Athanasios G. Pantelis,
  • Beniamino Pascotto,
  • Tadeja Pintar Kaliterna,
  • Luis Poggi,
  • Dimitri J. Pournaras,
  • Sjaak Pouwels,
  • Arun Prasad,
  • Luiz Gustavo Quadros,
  • Farnaz Rahimi,
  • Masoud Rezvani,
  • Karl Peter Rheinwalt,
  • Rui Jose Da Silva Ribeiro,
  • Rizzo Esselin de Melo,
  • Andrew G. Robertson,
  • Angelica Katherine Romero Suarez,
  • Mitchell Steven Roslin,
  • Edgardo Andrevis Saavedra Chávez,
  • Alan Saber,
  • Nasser Sakran,
  • Sergio Santoro,
  • Felix Antonio Santos,
  • Hugo Santos Sousa,
  • Antelmo Sasso Fin,
  • Romano Schneider,
  • Yosuke Seki,
  • Edgardo Emilio Serra,
  • Alaa Mostafa Sewefy,
  • Asim Shabbir,
  • Shahab Shahabi Shahmiri,
  • Arya Mitra Sharma,
  • Ghulam Siddiq,
  • Rishi Singhal,
  • Mehdi Skalli,
  • Erik Stenberg,
  • Michel Suter,
  • Safwan Taha,
  • Hany Takla,
  • Halit Eren Taskin,
  • Ali Tavakkoli,
  • Tigran Poghosyan,
  • Salvatore Tolone,
  • Antonio Jose Torres,
  • Pim Van Rutte,
  • Carlos Vaz,
  • José Sergio Verboonen,
  • Ramon Vilallonga,
  • Antonio Vitiello,
  • Paula Volpe,
  • Ala Wafa,
  • Joe Joaquim Junior Waltrick,
  • Cunchuan Wang,
  • Sylvia Weiner,
  • Richard Welbourn,
  • Wah Yang,
  • Tahir Ebrahim Yunus,
  • Ricardo Zorron,
  • Natan Zundel

摘要

The prevalence of revision and conversion metabolic bariatric surgery (MBS) has increased alongside the growing number of primary Roux-en-Y gastric bypass (RYGB) procedures performed worldwide. Common indications for revision or conversion after RYGB include weight recurrence (WR), suboptimal clinical response (SoCR), and late postoperative complications such as internal hernia, marginal ulcers, malnutrition, dumping syndrome, and post-bariatric hypoglycemia. However, high-quality comparative evidence remains limited, and no international consensus exists regarding optimal management strategies. This study aimed to evaluate current international practices and expert opinions on revision and conversion surgery after RYGB through a global expert survey. This international online binary survey comprised 61 questions and was conducted via SurveyMonkey™ between November 14 and December 10, 2025. A total of 188 specialists participated (75.2% of invitees), with 184 completing the questionnaire (98% completion rate). Item-specific response rates ranged from 177 to 187. The survey demonstrated broad international agreement that WR and SoCR are multifactorial conditions requiring individualized, multidisciplinary management. Endoscopic approaches were generally favored as first-line options in selected patients with anatomical dilation, whereas hypoabsorptive procedures (distal RYGB, SADI-S, BPD-DS) were considered more effective for long-term weight loss and metabolic outcomes. High agreement (> 90%) was observed for multidisciplinary follow-up, individualized procedure selection, lifelong nutritional surveillance, and management of several late complications. Important areas of controversy remain. These findings provide preliminary insights that may support future standardized definitions, clinical pathways, and evidence-based guidelines.